Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Brooklyn ImmunoTherapeutics Announces Name Change To Eterna Therapeutics And Provides Corporate Updates

Author: Benzinga Newsdesk | October 11, 2022 08:35am

New name reflects Company focus on leveraging exclusively in-licensed foundational mRNA cell engineering patent portfolio
 

The Eterna corporate mission is to realize the potential of cell engineering to provide patients with transformational new medicines

Company's shares to trade under new ticker symbol "ERNA" starting on October 17, 2022, and a one-for-twenty share consolidation will become effective on that date

Posted In: BTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist